The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection
Open accessAbstract
In contrast with other vascularized allografts, chronic liver allograft rejection is uncommon.Over the last two decades, the incidence at 5 years after transplantation has decreased from 15% to 20% in the 1980s to an expected incidence of 3% to 5% in current liver allograft recipients. 1 This is likely attributable to the unique immunologic properties of a liver allograft, better recognition and control of acute and the early phases of chronic rejection (CR), and the remarkable regenerative capabilities of the liver.[2][3][4][5][6][7][8][9][10][11] Nevertheless, CR is still an important cause of late liver allograft dysfunction and failure.[12][13][14][15][16] And from a practical perspective, proper recognition and staging of CR is essential for long-term patient management, because toxic side effects of long-term immunosuppression force clinicians to significantly lower or discontinue immunosuppression.[17][18][19][20] Moreover, given the inevitable decline in kidney and heart allograft structure and function because of CR, study of the relatively low incidence of CR in liver allografts, and the ability of the liver to recover from CR, will likely lead to valuable insights into transplantation immunobiology in general.In a previous consensus publication by the Banff Working Group, 21 the panel constructed a working schema for grading acute liver allograft rejection, which has subsequently proven to be simple, reliable, clinically relevant and scientifically correct.22,23 It is used to grade the necroinflammatory activity of acute rejection that is potentially amenable to therapeutic intervention.At the 5th Banff Conference on Allograft Pathology in 1999, the main goal of the liver sessions was to identify the various stages in the evolution of CR, with the specific aim of addressing two main questions: (1) Can histopathologic features be identified at an early stage of CR, which if left untreated, are predictive of progression to graft failure?This has important clinical implications, because such cases may still be potentially reversible with the use of additional immunosuppression; and (2) Can histopathologic features be used to indicate that irreversible graft damage has occurred?This question also has obvious important clinical implications, because such cases are likely to be unresponsive to additional immunosuppression and depending on the complete clinicopathological profile, may require relisting for retransplantation.An important related issue is whether there are atypical patterns of chronic liver allograft rejection, which appear very similar or identical to chronic hepatitis and lead to cirrhosis, in contrast with the more commonly recognized pattern of CR. MATERIALS AND METHODSDuring the two years since the 4th Banff Consensus conference in 1997, investigators from several large programs and the NIDDK liver transplant database, studied various aspects of chronic liver allograft rejection, including clinical and demographic factors 11,24,25 and histopathologic findings associated with the evolution [26][27][28] and/or reversal or progression to allograft failure.11,27,29 Abstracts of these works [25][26][27][28][29] can be viewed at: http://tpis.upmc.edu/tpis/Banff/1999/index.html#Subjectsand Titles.The findings from these studies were presented and discussed at the 5th Banff Conference.The working formulation and recommendations below, are based on these studies of more than 2,500 liver allograft recipients in more than 7 centers throughout the world, in combination with previous publications on CR and considerable combined clinical and pathological experience of the Banff Panel on Allograft Pathology. RESULTS Definition and Relationship to Acute Rejection.Chronic liver allograft rejection can be defined as an immunologic injury to the allograft, which usually evolves from severe or persistent acute rejection and results in potentially irreversible damage
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
Demetris, A. J., Batts, K. P., Dhillon, A. P., Ferrell, L., Fung, J., Geller, S. A., Hart, J., Hayry, P., Hofmann, W. J., Hubscher, S., et al. (1997) · Hepatology · doi:10.1002/hep.510250328 · Cited by 1,272
Cell migration, chimerism, and graft acceptance
Starzl, T. E., Murase, N., Ildstad, S., Ricordi, C., Demetris, A. J., & Trucco, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91840-5 · Cited by 1,051
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
Starzl, T., Fung, J., Venkataramman, R., Todo, S., Demetris, A., & Jain, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91014-3 · Cited by 1,035
(1994) · The Lancet · doi:10.1016/s0140-6736(94)91766-3 · Cited by 656
Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †
Wiesner, R. H., Demetris, J. A., Belle, S. H., Seaberg, E. C., Lake, J. R., Zetterman, R. K., Everhart, J., & Detre, K. M. (1998) · Hepatology · doi:10.1002/hep.510280306 · Cited by 495
Rethinking Chronic Allograft Nephropathy: The Concept of Accelerated Senescence
HALLORAN, P. F., MELK, A., & BARTH, C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v101167 · Cited by 452
WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS12
Mazariegos, G. V., Reyes, J., Marino, I. R., Demetris, A. J., Flynn, B., Irish, W., McMichael, J., Fung, J. J., & Starzl, T. E. (1997) · Transplantation · doi:10.1097/00007890-199701270-00012 · Cited by 411
Kandela, P. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90538-0 · Cited by 333
The normal adult human liver biopsy: A quantitative reference standard
Crawford, A. R., Lin, X.-Z., & Crawford, J. M. (1998) · Hepatology · doi:10.1002/hep.510280206 · Cited by 315
Cited by
Liver biopsy interpretation for causes of late liver allograft dysfunction
(2006) · Hepatology · doi:10.1002/hep.21280 · Cited by 359
Autoimmune liver disease, autoimmunity and liver transplantation
Carbone, M., & Neuberger, J. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.020 · Cited by 250
Liver transplantation immunology: immunosuppression, rejection, and immunomodulation
Montano-Loza, A. J., Rodríguez-Perálvarez, M. L., Pageaux, G.-P., Sanchez-Fueyo, A., & Feng, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.030 · Cited by 208
Lucey, M. R., Furuya, K. N., & Foley, D. P. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2200923 · Cited by 182
New Developments and Challenges in Liver Transplantation
Khalil, A., Quaglia, A., Gélat, P., Saffari, N., Rashidi, H., & Davidson, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175586 · Cited by 40
Metadata
- Venue
- Hepatology
- Published
- 2000-03
- Volume
- 31
- Issue
- 3
- Pages
- 792-799
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1585321597
- Cited by
- 543
- References
- 43
- FWCI
- 21.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. https://app.cochat.ai/papers/10.1002/hep.510310337
- The paper
- Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection. (2000). Hepatology. https://doi.org/10.1002/hep.510310337
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.